
The global Skin Microbiome Modulator market size is predicted to grow from US$ 893 million in 2025 to US$ 2367 million in 2031; it is expected to grow at a CAGR of 17.6% from 2025 to 2031.
Microbiome modulation enables us to select and combine beneficial bacteria within skincare products in order to rebalance a diseased skin microbiome.Microbiome forms an integral part of any human being. The presence is of paramount importance in all cavities of the human body and on our skin. Skin microbiome keep the organ from malfunctioning and assist in a variety of functions like sweat production, temperature maintenance among others.For years, the microbiome has been targeted as a source of potential infection by personal care products. But focus is shifting from working against them to working with them. A modulation of the skin microbiome works by inserting genes that activate a counter response to damage by external factors like excessive sunlight and dust.
Global key skin microbiome modulator manufacturers include L’Oréal S.A., Unilever, The Estée Lauder Companies etc.The top 3 companies hold a share about 27%.Americas is the largest market, with a share about 33%, followed by APAC and Europe with the share about 32% and 26%.
The “Skin Microbiome Modulator Industry Forecast†looks at past sales and reviews total world Skin Microbiome Modulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Skin Microbiome Modulator sales for 2025 through 2031. With Skin Microbiome Modulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Skin Microbiome Modulator industry.
This Insight Report provides a comprehensive analysis of the global Skin Microbiome Modulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Skin Microbiome Modulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Skin Microbiome Modulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Skin Microbiome Modulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Skin Microbiome Modulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Skin Microbiome Modulator market by product type, application, key players and key regions and countries.
Segmentation by Type:
Probiotics
Prebiotics
Drugs
Segmentation by Application:
Skin Care
Hair Care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
L’Oréal S.A.
Unilever
The Estée Lauder Companies
Johnson & Johnson
Revlon
Evelo Biosciences
AOBiome
Azitra
³Ò´¡³¢³¢±õ±·Ã‰·¡
Glowbiotics
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Skin Microbiome Modulator Market Size (2020-2031)
2.1.2 Skin Microbiome Modulator Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Skin Microbiome Modulator by Country/Region (2020, 2024 & 2031)
2.2 Skin Microbiome Modulator Segment by Type
2.2.1 Probiotics
2.2.2 Prebiotics
2.2.3 Drugs
2.3 Skin Microbiome Modulator Market Size by Type
2.3.1 Skin Microbiome Modulator Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Skin Microbiome Modulator Market Size Market Share by Type (2020-2025)
2.4 Skin Microbiome Modulator Segment by Application
2.4.1 Skin Care
2.4.2 Hair Care
2.4.3 Others
2.5 Skin Microbiome Modulator Market Size by Application
2.5.1 Skin Microbiome Modulator Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Skin Microbiome Modulator Market Size Market Share by Application (2020-2025)
3 Skin Microbiome Modulator Market Size by Player
3.1 Skin Microbiome Modulator Market Size Market Share by Player
3.1.1 Global Skin Microbiome Modulator Revenue by Player (2020-2025)
3.1.2 Global Skin Microbiome Modulator Revenue Market Share by Player (2020-2025)
3.2 Global Skin Microbiome Modulator Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Skin Microbiome Modulator by Region
4.1 Skin Microbiome Modulator Market Size by Region (2020-2025)
4.2 Global Skin Microbiome Modulator Annual Revenue by Country/Region (2020-2025)
4.3 Americas Skin Microbiome Modulator Market Size Growth (2020-2025)
4.4 APAC Skin Microbiome Modulator Market Size Growth (2020-2025)
4.5 Europe Skin Microbiome Modulator Market Size Growth (2020-2025)
4.6 Middle East & Africa Skin Microbiome Modulator Market Size Growth (2020-2025)
5 Americas
5.1 Americas Skin Microbiome Modulator Market Size by Country (2020-2025)
5.2 Americas Skin Microbiome Modulator Market Size by Type (2020-2025)
5.3 Americas Skin Microbiome Modulator Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Skin Microbiome Modulator Market Size by Region (2020-2025)
6.2 APAC Skin Microbiome Modulator Market Size by Type (2020-2025)
6.3 APAC Skin Microbiome Modulator Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Skin Microbiome Modulator Market Size by Country (2020-2025)
7.2 Europe Skin Microbiome Modulator Market Size by Type (2020-2025)
7.3 Europe Skin Microbiome Modulator Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Skin Microbiome Modulator by Region (2020-2025)
8.2 Middle East & Africa Skin Microbiome Modulator Market Size by Type (2020-2025)
8.3 Middle East & Africa Skin Microbiome Modulator Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Skin Microbiome Modulator Market Forecast
10.1 Global Skin Microbiome Modulator Forecast by Region (2026-2031)
10.1.1 Global Skin Microbiome Modulator Forecast by Region (2026-2031)
10.1.2 Americas Skin Microbiome Modulator Forecast
10.1.3 APAC Skin Microbiome Modulator Forecast
10.1.4 Europe Skin Microbiome Modulator Forecast
10.1.5 Middle East & Africa Skin Microbiome Modulator Forecast
10.2 Americas Skin Microbiome Modulator Forecast by Country (2026-2031)
10.2.1 United States Market Skin Microbiome Modulator Forecast
10.2.2 Canada Market Skin Microbiome Modulator Forecast
10.2.3 Mexico Market Skin Microbiome Modulator Forecast
10.2.4 Brazil Market Skin Microbiome Modulator Forecast
10.3 APAC Skin Microbiome Modulator Forecast by Region (2026-2031)
10.3.1 China Skin Microbiome Modulator Market Forecast
10.3.2 Japan Market Skin Microbiome Modulator Forecast
10.3.3 Korea Market Skin Microbiome Modulator Forecast
10.3.4 Southeast Asia Market Skin Microbiome Modulator Forecast
10.3.5 India Market Skin Microbiome Modulator Forecast
10.3.6 Australia Market Skin Microbiome Modulator Forecast
10.4 Europe Skin Microbiome Modulator Forecast by Country (2026-2031)
10.4.1 Germany Market Skin Microbiome Modulator Forecast
10.4.2 France Market Skin Microbiome Modulator Forecast
10.4.3 UK Market Skin Microbiome Modulator Forecast
10.4.4 Italy Market Skin Microbiome Modulator Forecast
10.4.5 Russia Market Skin Microbiome Modulator Forecast
10.5 Middle East & Africa Skin Microbiome Modulator Forecast by Region (2026-2031)
10.5.1 Egypt Market Skin Microbiome Modulator Forecast
10.5.2 South Africa Market Skin Microbiome Modulator Forecast
10.5.3 Israel Market Skin Microbiome Modulator Forecast
10.5.4 Turkey Market Skin Microbiome Modulator Forecast
10.6 Global Skin Microbiome Modulator Forecast by Type (2026-2031)
10.7 Global Skin Microbiome Modulator Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Skin Microbiome Modulator Forecast
11 Key Players Analysis
11.1 L’Oréal S.A.
11.1.1 L’Oréal S.A. Company Information
11.1.2 L’Oréal S.A. Skin Microbiome Modulator Product Offered
11.1.3 L’Oréal S.A. Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 L’Oréal S.A. Main Business Overview
11.1.5 L’Oréal S.A. Latest Developments
11.2 Unilever
11.2.1 Unilever Company Information
11.2.2 Unilever Skin Microbiome Modulator Product Offered
11.2.3 Unilever Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Unilever Main Business Overview
11.2.5 Unilever Latest Developments
11.3 The Estée Lauder Companies
11.3.1 The Estée Lauder Companies Company Information
11.3.2 The Estée Lauder Companies Skin Microbiome Modulator Product Offered
11.3.3 The Estée Lauder Companies Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 The Estée Lauder Companies Main Business Overview
11.3.5 The Estée Lauder Companies Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Skin Microbiome Modulator Product Offered
11.4.3 Johnson & Johnson Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Revlon
11.5.1 Revlon Company Information
11.5.2 Revlon Skin Microbiome Modulator Product Offered
11.5.3 Revlon Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Revlon Main Business Overview
11.5.5 Revlon Latest Developments
11.6 Evelo Biosciences
11.6.1 Evelo Biosciences Company Information
11.6.2 Evelo Biosciences Skin Microbiome Modulator Product Offered
11.6.3 Evelo Biosciences Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Evelo Biosciences Main Business Overview
11.6.5 Evelo Biosciences Latest Developments
11.7 AOBiome
11.7.1 AOBiome Company Information
11.7.2 AOBiome Skin Microbiome Modulator Product Offered
11.7.3 AOBiome Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 AOBiome Main Business Overview
11.7.5 AOBiome Latest Developments
11.8 Azitra
11.8.1 Azitra Company Information
11.8.2 Azitra Skin Microbiome Modulator Product Offered
11.8.3 Azitra Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Azitra Main Business Overview
11.8.5 Azitra Latest Developments
11.9 ³Ò´¡³¢³¢±õ±·Ã‰·¡
11.9.1 ³Ò´¡³¢³¢±õ±·Ã‰·¡ Company Information
11.9.2 ³Ò´¡³¢³¢±õ±·Ã‰·¡ Skin Microbiome Modulator Product Offered
11.9.3 ³Ò´¡³¢³¢±õ±·Ã‰·¡ Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 ³Ò´¡³¢³¢±õ±·Ã‰·¡ Main Business Overview
11.9.5 ³Ò´¡³¢³¢±õ±·Ã‰·¡ Latest Developments
11.10 Glowbiotics
11.10.1 Glowbiotics Company Information
11.10.2 Glowbiotics Skin Microbiome Modulator Product Offered
11.10.3 Glowbiotics Skin Microbiome Modulator Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Glowbiotics Main Business Overview
11.10.5 Glowbiotics Latest Developments
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.
